ID   Ba/F3 EGFR [Taiho Pharmaceutical]
AC   CVCL_E6DF
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=29748209; DOI=10.1158/1535-7163.MCT-17-1206;
RA   Hasako S., Terasaka M., Abe N., Uno T., Ohsawa H., Hashimoto A.,
RA   Fujita R., Tanaka K., Okayama T., Wadhwa R., Miyadera K., Aoyagi Y.,
RA   Yonekura K., Matsuo K.;
RT   "TAS6417, a novel EGFR inhibitor targeting exon 20 insertion
RT   mutations.";
RL   Mol. Cancer Ther. 17:1648-1658(2018).
//